Creatv Bio division of Creatv MicroTech Inc

• Booth: 31088

Creatv provides the following blood tests applicable to all solid tumors, all stages of cancer and all therapies. Creatv’s blood tests can screen for cancer and provide prognosis at the same time. • Screen for single cancer or pan cancers • Detect minimal residual disease at end of therapy • Detect recurrence earlier than imaging Creatv’s blood tests can also provide many diagnostic applications. • Predict treatment response to new therapy just 30 days after first therapy • Companion/complementary diagnostics • Prognosis • Provide copious unfragmented tumor DNA for sequencing